Cannabinoid and orexigenic systems interplay as a new focus of research in alzheimer’s disease

HIGHLIGHTS

• What: The study of the heteromers formed by OXR-CBR becomes a new focus of research in finding new potential therapeutic targets for this disease. The authors propose in_vitro testing of inflammation markers, oxidative stress and AB presence/transport using primary cultures of neurons and microglia of the orexin receptor KO animals.
• Who: Joan Biel Rebassa and collaborators from the Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas (CiberNed), National Institute Institut de Neurociències UB, Campus Mundet, Barcelona, Spain Department of Biochemistry and Physiology, Faculty of Pharmacy and Food Science, University of . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.